Preferred Pharmaceuticals Losartan HCTZ Tablets Recall: AZIDO Impurity Risk
Preferred Pharmaceuticals recalls Losartan Potassium & HCTZ 50mg/12.5mg tablets with AZIDO impurities above safe levels. Consumers should check lot numbers and contact the company for details.
“Preferred Pharmaceuticals Losartan HCTZ Tablets Recall: AZIDO Impurity Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34798-preferred-pharmaceuticals-losartan-hctz-tablets-recall-azido-impurity-risk. Based on FDA recall #D-0891-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0891-2022%22&limit=1).
The FDA announced on May 3, 2022, that Preferred Pharmaceuticals voluntarily recalled Losartan Potassium & HCTZ Tablets due to azido impurity levels exceeding acceptable limits. The recall affects specific lots distributed in Florida and California.
Lot Codes: K1721D (EXP: 4/30/2023), K1021E (EXP: 7/31/2023)
Distribution: Within the U.S. in FL and CA
The hazard
The recall was issued because current Good Manufacturing Practice (CGMP) deviations resulted in azido impurity levels being observed above acceptable limits. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Preferred Pharmaceuticals, Inc. has had 31 other recalls on record since August 15, 2018. Other recent recalls of similar products include Geri-Care Eye Drops Recalled for Sterility Risk (March 25, 2026), Preferred Pharma Recalls Ondansetron ODT Due to Defective Seals (November 17, 2025), and Preferred Pharma Recalls Clindamycin Capsules Due to cGMP Deviations (April 18, 2025). Other recent recalls of similar products include Unichem Bisoprolol/Hydrochlorothiazide Tablets Recall: N-Nitroso Impurity Risk (January 21, 2026), Zydus Mirabegron 25mg Tablets Recall: N-Nitroso Impurity Risk (August 5, 2026), and Sun Pharmaceutical Fexofenadine 180mg Tablets Recall: Impurities Risk Safety (June 1, 2026).
How to tell if you have this one
Check the lot number on the packaging: K1721D (expires 4/30/2023) or K1021E (expires 7/31/2023). The product is a 90-tablet package with NDC 68788-7758-09.
Brand
Preferred Pharmaceuticals
Category
Drug
FDA recall event · 2 products
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0891-2022 (May 3, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0891-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.